Serum fetuin-A levels and abdominal aortic calcification in healthy men - The STRAMBO study

Bone

Volumn 79, Issue , 2015, Pages 196-202

  Schoppet, Michael ^a   Rauner, Martina ^b,e   Benner, Jacqueline ^c   Chapurlat, Roland ^d   Hofbauer, Lorenz C ^b,e   Szulc, Pawel ^d  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^d The Antibody Lab   (Austria)

^e UNIVERSITÉ DE LYON   (France)

Author keywords

Abdominal aorta calcification; Calcification inhibitor; Fetuin A; Men; Mineral homeostasis

Indexed keywords

BIOLOGICAL MARKER; DICKKOPF 1 PROTEIN; FETUIN A; FIBROBLAST GROWTH FACTOR 23; AHSG PROTEIN, HUMAN;

AAC SCORE; ABDOMINAL AORTIC CALCIFICATION; ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD ANALYSIS; BODY COMPOSITION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSESSMENT; DISEASE SEVERITY; DOWN REGULATION; DUAL ENERGY X RAY ABSORPTIOMETRY; GLOMERULUS FILTRATION RATE; HEALTH INSURANCE; HEALTH STATUS; HUMAN; HYPERTENSION; IMMUNOASSAY; LIFESTYLE; MALE; NORMAL HUMAN; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; SMOKING HABIT; ABDOMINAL AORTA; AGED; BLOOD; BLOOD VESSEL CALCIFICATION; MIDDLE AGED; PATHOLOGY; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; VERY ELDERLY; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; ALPHA-2-HS-GLYCOPROTEIN; AORTA, ABDOMINAL; BIOMARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84945451116     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.06.004     Document Type: Article

References (49)

1. Shroff R.C., Shanahan C.M. The vascular biology of calcification. Semin Dial 2007, 20:103-109.
2. Santos R.D., Rumberger J.A., Budoff M.J., Shaw L.J., Orakzai S.H., Berman D., et al. Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality. Atherosclerosis 2010, 209:131-135.
3. Eisen A., Tenenbaum A., Koren-Morag N., Tanne D., Shemesh J., Imazio M., et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 2008, 118:1328-1334.
4. Schoppet M., Shroff R.C., Hofbauer L.C., Shanahan C.M. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?. Kidney Int 2008, 73:384-390.
5. DeLoach S.S., Joffe M.M., Mai X., Goral S., Rosas S.E. Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation. Nephrol Dial Transplant 2009, 24:1314-1319.
6. Okuno S., Ishimura E., Kitatani K., Fujino Y., Kohno K., Maeno Y., et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007, 49:417-425.
7. Jahnen-Dechent W., Heiss A., Schäfer C., Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ Res 2011, 108:1494-1509.
8. Schafer C., Heiss A., Schwarz A., Westenfeld R., Ketteler M., Floege J., et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003, 112:357-366.
9. Westenfeld R., Schäfer C., Krüger T., Haarmann C., Schurgers L.J., Reutelingsperger C., et al. Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol 2009, 20:1264-1274.
10. Laughlin G.A., Cummins K.M., Wassel C.L., Daniels L.B., Ix J.H. The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study. J Am Coll Cardiol 2012, 59:1688-1696.
11. Roos M., von Eynatten M., Heemann U., Rothenbacher D., Brenner H., Breitling L.P. Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 2010, 105:1666-1672.
12. Stenvinkel P., Wang K., Qureshi A.R., Axelsson J., Pecoits-Filho R., Gao P., et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005, 67:2383-2392.
13. Lim P., Moutereau S., Simon T., Gallet R., Probst V., Ferrieres J., et al. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]). Am J Cardiol 2013, 111:31-37.
14. Weikert C., Stefan N., Schulze M.B., Pischon T., Berger K., Joost H.G., et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008, 118:2555-2562.
15. Ix J.H., Shlipak M.G., Brandenburg V.M., Ali S., Ketteler M., Whooley M.A. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006, 113:1760-1767.
16. Jiménez M.C., Sun Q., Schürks M., Hu F.B., Manson J.E., Rexrode K.M. Circulating fetuin-A and risk of ischemic stroke in women. Clin Chem 2014, 60:165-173.
17. Moe S.M., Reslerova M., Ketteler M., O'Neill K., Duan D., Koczman J., et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005, 67:2295-2304.
18. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Böhm R., et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003, 361:827-833.
19. Koos R., Brandenburg V., Mahnken A.H., Mühlenbruch G., Stanzel S., Günther R.W., et al. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients. Eur Heart J 2009, 30:2054-2061.
20. Emoto M., Mori K., Lee E., Kawano N., Yamazaki Y., Tsuchikura S., et al. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabolism 2010, 59:873-878.
21. Chaitou A., Boutroy S., Vilayphiou N., Munoz F., Delmas P.D., Chapurlat R., et al. Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study. J Bone Miner Res 2010, 25:2313-2323.
22. Szulc P., Munoz F., Marchand F., Chapuy M.C., Delmas P.D. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Calcif Tissue Int 2003, 73:520-530.
23. Chaitou A., Boutroy S., Vilayphiou N., Varennes A., Richard M., Blaizot S., et al. Association of bone microarchitecture with parathyroid hormone concentration and calcium intake in men: the STRAMBO study. Eur J Endocrinol 2011, 165:151-159.
24. Argoud T., Boutroy S., Claustrat B., Chapurlat R., Szulc P. Association between sex steroid levels and bone microarchitecture in men: the STRAMBO study. J Clin Endocrinol Metab 2014, 99:1400-1410.
25. Schoppet M., Hofbauer L.C., Brinskelle-Schmal N., Varennes A., Goudable J., Richard M., et al. Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. J Clin Endocrinol Metab 2012, 97:E575-E583.
26. Szulc P., Schoppet M., Goettsch C., Rauner M., Dschietzig T., Chapurlat R., et al. Endocrine and clinical correlates of myostatin serum concentration in men - the STRAMBO study. J Clin Endocrinol Metab 2012, 97:3700-3708.
27. Szulc P., Hawa G., Boutroy S., Vilayphiou N., Schoppet M., Chapurlat R., et al. Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. J Clin Endocrinol Metab 2011, 96:2216-2226.
28. Rolland T., Boutroy S., Vilayphiou N., Blaizot S., Chapurlat R., Szulc P. Poor trabecular microarchitecture at the distal radius in older men with increased concentration of high-sensitivity C-reactive protein - the STRAMBO study. Calcif Tissue Int 2012, 90:496-506.
29. Szulc P., Schoppet M., Rachner T.D., Chapurlat R., Hofbauer L.C. Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: the STRAMBO study. J Clin Endocrinol Metab 2014, 99:617-624.
30. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
31. Szulc P., Samelson E.J., Sornay-Rendu E., Chapurlat R., Kiel D.P. Severity of aortic calcification is positively associated with vertebral fracture in older men - a densitometry study in the STRAMBO cohort. Osteoporos Int 2013, 24:1177-1184.
32. Kauppila L.I., Polak J.F., Cupples L.A., Hannan M.T., Kiel D.P., Wilson P.W. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
33. Rennenberg R.J., Kessels A.G., Schurgers L.J., van Engelshoven J.M., de Leeuw P.W., Kroon A.A. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 2009, 5:185-197.
34. Westenfeld R., Schäfer C., Smeets R., Brandenburg V.M., Floege J., Ketteler M., Jahnen-Dechent W. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 2007, 22:1537-1546.
35. Porazko T., Kuźniar J., Kusztal M., Kuźniar T.J., Weyde W., Kuriata-Kordek M., et al. Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients. Nephron Clin Pract 2009, 113:c81-c87.
36. Pateinakis P., Papagianni A., Douma S., Efstratiadis G., Memmos D. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. BMC Nephrol 2013, 14:122.
37. Tuttolomondo A., Di Raimondo D., Di Sciacca R., Casuccio A., Bivona G., Bellia C., et al. Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis 2010, 208:290-296.
38. Ix J.H., Katz R., de Boer I.H., Kestenbaum B.R., Peralta C.A., Jenny N.S., et al. Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis. Clin Chem 2012, 58:887-895.
39. Ix J.H., Barrett-Connor E., Wassel C.L., Cummins K., Bergstrom J., Daniels L.B., et al. The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 2011, 58:2372-2379.
40. Sekikawa A., Shin C., Curb J.D., Barinas-Mitchell E., Masaki K., El-Saed A., et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis 2012, 222:473-477.
41. Roos M., Richart T., Kouznetsova T., von Eynatten M., Lutz J., Heemann U., et al. Fetuin-A and arterial stiffness in patients with normal kidney function. Regul Pept 2009, 154:39-43.
42. Lim P., Collet J.P., Moutereau S., Guigui N., Mitchell-Heggs L., Loric S., et al. Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem 2007, 53:1835-1840.
43. Mathews S.T., Deutsch D.D., Iyer G., Hora N., Pati B., Marsh J., et al. Plasma alpha2-HS glycoprotein concentrations in patients with acute myocardial infarction quantified by a modified ELISA. Clin Chim Acta 2002, 319:27-34.
44. Shah A., Miller C.J., Nast C.C., Adams M.D., Truitt B., Tayek J.A., et al. Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. Nephrol Dial Transplant 2014, 29:2235-2243.
45. Lorant D.P., Grujicic M., Hoebaus C., Brix J.M., Hoellerl F., Schernthaner G., et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care 2011, 34:156-161.
46. Lappin D.F., Sherrabeh S., Jenkins W.M., Macpherson L.M. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. J Clin Periodontol 2007, 34:271-277.
47. Smith E.R., Ford M.L., Tomlinson L.A., Rocks B.F., Rajkumar C., Holt S.G. Poor agreement between commercial ELISAs for plasma fetuin-A: an effect of protein glycosylation?. Clin Chim Acta 2010, 411:1367-1370.
48. Smith E.R., Ford M.L., Tomlinson L.A., Rajkumar C., McMahon L.P., Holt S.G. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 2012, 27:1957-1966.
49. Smith E.R., Cai M.M., McMahon L.P., Pedagogos E., Toussaint N.D., Brumby C., et al. Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure. Nephrology 2013, 18:215-221.